Wechselwirkungen · Pemetrexed Fresenius Kabi
Pemetrexed Fresenius Kabi 100 mg powder for concentrate for solution for infusion · Abschnitt 4.5 · PDF-Seite 7–8
HOS-221203 · Präparat HOS-216804
Concomitant use contraindicated: Yellow fever vaccine: risk of fatal generalised vaccinale disease (see section 4.3). 7 Concomitant use not recommended: Live attenuated vaccines (except yellow fever, for which concomitant use is contraindicated): risk of systemic, possibly fatal, disease. The risk is increased in subjects who are already immunosuppressed by their underlying disease. Use an inactivated vaccine where it exists (poliomyelitis) (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-02-12T18:17:00Z · SHA-256 92d1903698b62747386c44108aad128905421496a3b541278d5d3734a65f70bc · Passage 7a0e43824d3674412424041327a0626b33b018fa5cf8482e70d0046b21ff7991 · Zeichen 2880–3393 im Abschnitt